Ruozhi Xiao
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- NF-κB Signaling Pathways 3
-
- Peroxisome Proliferator-Activated Receptors 4
- Cell death mechanisms and regulation 3
- Circular RNAs in diseases 3
-
- Acute Myeloid Leukemia Research 4
-
- interferon and immune responses 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Zhigang FangJiajun LiuJieying WuGuangjin PanPeiqing LiuRenwei HuangYong ZhangDong-Jun Lin
- Journals
- International Journal of Molecular Sciences (2 papers)Journal of Experimental & Clinical Cancer Research (1 paper)Bioscience Biotechnology and Biochemistry (1 paper)
- Partner nations
- China
In The Last Decade
Ruozhi Xiao
23 papers receiving 446 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 216
- Complementary and alternative medicine 44
- Molecular Biology 365
- Hematology 47
- Toxicology 9
Countries citing papers authored by Ruozhi Xiao
This map shows the geographic impact of Ruozhi Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruozhi Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruozhi Xiao more than expected).
Fields of papers citing papers by Ruozhi Xiao
This network shows the impact of papers produced by Ruozhi Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruozhi Xiao. The network helps show where Ruozhi Xiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruozhi Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 5 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 9 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 96 | |
| 9 | 2018 | 67 | |
| 10 | 2014 | 2 | |
| 11 | 2013 | 4 | |
| 12 | 2013 | 9 | |
| 13 | 2013 | 7 | |
| 14 | 2011 | 29 | |
| 15 | 2010 | 49 | |
| 16 | 2010 | 18 | |
| 17 | 2010 | 36 | |
| 18 | 2009 | 6 | |
| 19 | 2008 | 22 | |
| 20 | 2006 | 30 |
About Ruozhi Xiao
Ruozhi Xiao is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 23 papers that have together received 451 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), MicroRNA in disease regulation (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Cell death mechanisms and regulation (3 papers), Circular RNAs in diseases (3 papers), NF-κB Signaling Pathways (3 papers), interferon and immune responses (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (216 citations), Complementary and alternative medicine (44 citations) and Molecular Biology (365 citations). Ruozhi Xiao has collaborated with scholars based in China. Frequent co-authors include Zhigang Fang, Jiajun Liu, Jieying Wu, Guangjin Pan, Peiqing Liu, Renwei Huang, Yong Zhang, Jiajun Liu, Dong-Jun Lin and Ling Zhang. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research and Bioscience Biotechnology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.